Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,750.00p
   
  • Change Today:
    -100.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 2,289
  • Market Cap: £143.68m

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £8,169,920
Ian James Nicholson 13,000 £357,500
Bruce Hiscock 1,236 £33,990

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £143,540,540
Castlefield Fund Partners Limited 985,000 £27,087,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £24,337,500
Gresham House Asset Management Limited 627,782 £17,264,005
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £17,036,250
Miton Group plc 508,135 £13,973,712
The Diverse Income Trust plc 302,300 £8,313,250
Schroders plc 284,795 £7,831,862
Wasatch Advisors, Inc. 265,000 £7,287,500
Canaccord Genuity Group Inc 259,940 £7,148,350
Adrian Williams 253,372 £6,967,730

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,750.00p
Change Today -100.00p
% Change -3.51 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 2,289
Shares Issued 5.22m
Market Cap £143.68m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.39% below the market average21.39% below the market average21.39% below the market average21.39% below the market average21.39% below the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Price Trend
64% below the market average64% below the market average64% below the market average64% below the market average64% below the market average
30.43% below the sector average30.43% below the sector average30.43% below the sector average30.43% below the sector average30.43% below the sector average
Income
42.47% above the market average42.47% above the market average42.47% above the market average42.47% above the market average42.47% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
14.04% below the market average14.04% below the market average14.04% below the market average14.04% below the market average14.04% below the market average
26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 06-Jun-2025

Time Volume / Share Price
15:47 1,056 @ 2,740.00p
16:03 25 @ 2,770.00p
15:51 1 @ 2,800.00p
15:50 4 @ 2,700.00p
15:48 2 @ 2,792.50p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page